Graphene-based platforms for cancer therapeutics

Therapeutic Delivery

Volumn 7, Issue 2, 2016, Pages 101-116

  Patel, Sunny C ^a   Lee, Stephen ^a   Lalwani, Gaurav ^a   Suhrland, Cassandra ^a   Chowdhury, Sayan Mullick ^b   Sitharaman, Balaji ^a  

^a St Francis Hospital The Heart Center   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

biocompatibility; drug gene loading; graphene; photodynamic therapy; photothermal therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARBON NANOTUBE; CD20 ANTIBODY; DOXORUBICIN; FIRTECAN; FOLIC ACID; GRAPHENE; GRAPHENE OXIDE; HYALURONIC ACID; IRINOTECAN; METHYLENE BLUE; NANOMATERIAL; NANOPARTICLE; PACLITAXEL; PHOTOSENSITIZING AGENT; PLASMID DNA; PROTEIN TYROSINE KINASE INHIBITOR; PROTOPORPHYRIN; DRUG CARRIER; GRAPHITE; MICRORNA;

BIOCOMPATIBILITY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER THERAPY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; GENE DELIVERY SYSTEM; HELA CELL LINE; HUMAN; HYPERTHERMIC THERAPY; IN VITRO STUDY; IN VIVO STUDY; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; THERANOSTIC NANOMEDICINE; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENE TRANSFER; METABOLISM; NEOPLASMS; PHOTOCHEMOTHERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; GRAPHITE; HUMANS; MICRORNAS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84961378873     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.15.93     Document Type: Review

References (134)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics 2014. CACancer J. Clin. 64(1), 9-29 (2014).
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA-Cancer J. Clin. 65(2), 87-108 (2015).
3. Potash J, Anderson KC. AACR Cancer Progress Report 2014: Transforming Lives Through Research. Clin. Cancer Res. 20(19), 4977 (2014).
4. Siegel R, DeSantis C, Virgo K et al. Cancer treatment and survivorship statistics, 2012. CA-Cancer J. Clin. 62(4), 220-241 (2012).
5. Sahni V, Choudhury D, Ahmed Z. Chemotherapy-associated renal dysfunction. Nat. Rev. Nephrol. 5(8), 450-462 (2009).
6. Alexis F, Rhee J-W, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urol. Oncol. Semin. O I 26(1), 74-85 (2008).
7. Bharali DJ, Mousa SA. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol. Therapeut. 128(2), 324-335 (2010).
8. Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol. Oncol. Semin. O I 26(1), 57-64 (2008).
9. Davis ME, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9), 771-782 (2008).
10. Ruenraroengsak P, Cook JM, Florence AT. Nanosystem drug targeting: facing up to complex realities. J. Control. Release 141(3), 265-276 (2010).
11. Nichols JW, Bae YH. Odyssey of a cancer nanoparticle: from injection site to site of action. Nano Today 7(6), 606-618 (2012).
12. Allen MJ, Tung VC, Kaner RB. Honeycomb carbon: a review of graphene. Chem. Rev. 110, 132-145 (2010).
13. Geim AK, Novoselov KS. The rise of graphene. Nat. Mater. 6, 183-191 (2007).
14. Geim AK. Graphene: status and prospects. Science 324, 1530-1534 (2009).
15. Wang Y, Li Z, Wang J, Lisend J, Lin Y. Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol. 29, 205-212 (2011).
16. Jokar S, Pourjavadi A, Adeli M. Albumin-graphene oxide conjugates; carriers for anticancer drugs. RSC Adv. 4(62), 33001-33006 (2014).
17. Segal M. Selling graphene by the ton. Nat. Nanotechnol. 4, 612-614 (2009).
18. Talukdar Y, Rashkow JT, Lalwani G, Kanakia S, Sitharaman B. The effects of graphene nanostructures on mesenchymal stem cells. Biomaterials 35(18), 4863-4877 (2014).
19. Sun X, Liu Z, Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1(3), 203-212 (2008).
20. Paratala BS, Jacobson BD, Kanakia S, Francis LD, Sitharaman B. Physicochemical characterization, and relaxometry studies of micro-graphite oxide, graphene nanoplatelets, and nanoribbons. PLoS ONE 7(6), e38185 (2012).
21. Tonelli FM, Goulart VA, Gomes KN et al. Graphene-based nanomaterials: biological and medical applications and toxicity. Nanomedicine 10(15), 2423-2450 (2015).
22. Yang Y, Asiri AM, Tang Z, Du D, Lin Y. Graphene based materials for biomedical applications. Mater. Today 16(10), 365-373 (2013).
23. Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem. Soc. Rev. 42(2), 530-547 (2013).
24. Shen H, Zhang L, Liu M, Zhang Z. Biomedical applications of graphene. Theranostics 2(3), 283 (2012).
25. Zhang Y, Nayak TR, Hong H, Cai W. Graphene: a versatile nanoplatform for biomedical applications. Nanoscale 4(13), 3833-3842 (2012).
26. Wang XM, Zhang WH. Application of graphene derivatives in cancer therapy: a review. Carbon 67, 795 (2014).
27. Chung C, Kim YK, Shin D, Ryoo SR, Hong BH, Min DH. Biomedical applications of graphene and graphene oxide. Accounts Chem. Res. 46(10), 2211-2224 (2013).
28. Bitounis D, AliBoucetta H, Hong BH, Min DH, Kostarelos K. Prospects and challenges of graphene in biomedical applications. Adv. Mater. 25(16), 2258-2268 (2013).
29. Yang K, Zhang S, Zhang G, Sun X, Lee S-T, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 10(9), 3318-3323 (2010).
30. Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130(33), 10876-10877 (2008).
31. Yang X, Zhang X, Liu Z, Ma Y, Huang Y, Chen Y. Highefficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J. Phys. Chem. C 112(45), 17554-17558 (2008).
32. Zhang L, Xia J, Zhao Q, Liu L, Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6(4), 537-544 (2010).
33. Zhou T, Zhou X, Xing D. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier. Biomaterials 35(13), 4185-4194 (2014).
34. Wei G, Dong R, Wang D et al. Functional materials from the covalent modification of reduced graphene oxide and [small beta]-cyclodextrin as a drug delivery carrier. New J. Chem. 38(1), 140-145 (2014).
35. Xu Z, Zhu S, Wang M, Li Y, Shi P, Huang X. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier. App. Mater. Interfaces 7(2), 1355-1363 (2015).
36. Angelopoulou A, Voulgari E, Diamanti EK, Gournis D, Avgoustakis K. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel. Eur. J. Pharm. Biopharm. 93, 18-26 (2015).
37. Moore TL, Podilakrishna R, Rao A, Alexis F. Systemic administration of polymercoated nanographene to deliver drugs to glioblastoma. Part. Part. Syst. Char. 31(8), 886-894 (2014).
38. Qin XC, Guo ZY, Liu ZM, Zhang W, Wan MM, Yang BW. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. Photochem. Photobiol. 120, 156-162 (2013).
39. Zhao X, Liu P. Biocompatible graphene oxide as a folate receptor-targeting drug delivery system for the controlled release of anti-cancer drugs. RSC Adv. 4(46), 24232-24239 (2014).
40. Huang P, Xu C, Lin J et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 1, 240-250 (2011).
41. Lin Q, Huang X, Tang J, Han Y, Chen H. Environmentally friendly, one-pot synthesis of folic acid-decorated graphene oxide-based drug delivery system. J. Nanopart. Res. 15(12), 1-7 (2013).
42. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73(9), 2432-2443 (1994).
43. Yadav AK, Mishra P, Agrawal GP. An insight on hyaluronic acid in drug targeting and drug delivery. J. Drug Target. 16(2), 91-107 (2008).
44. Miao W, Shim G, Kang CM et al. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anticancer drug delivery. Biomaterials 34(37), 9638-9647 (2013).
45. Wu H, Shi H, Wang Y et al. Hyaluronic acid conjugated graphene oxide for targeted drug delivery. Carbon 69(0), 379-389 (2014).
46. Song E, Han W, Li C et al. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. App. Mater. Interfaces 6(15), 11882-11890 (2014).
47. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 121(2), 144-158 (2006).
48. Liu G, Shen H, Mao J et al. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. App. Mater. Interfaces 5(15), 6909-6914 (2013).
49. Liu G, Shen H, Mao J et al. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. App. Mater. Interfaces 5(15), 6909-6914 (2013).
50. Wang H, Gu W, Xiao N, Ye L, Xu Q. Chlorotoxinconjugated graphene oxide for targeted delivery of an anticancer drug. Int. J. Nanomed. 9, 1433-1442 (2014).
51. Mullick Chowdhury S, Lalwani G, Zhang K, Yang JY, Neville K, Sitharaman B. Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials 34(1), 283-293 (2013).
52. Mullick Chowdhury S, Surhland C, Sanchez Z et al. Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme. Nanomed. Nanotechnol. 11(1), 109-118 (2015).
53. Chowdhury SM, Lalwani G, Zhang K, Yang JY, Neville K, Sitharaman B. Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials 34(1), 283-293 (2013).
54. Mullick Chowdhury S, Manepalli P, Sitharaman B. Graphene nanoribbons elicit cell specific uptake and delivery via activation of epidermal growth factor receptor enhanced by human papillomavirus E5 protein. Acta Biomater. 10(10), 4494-4504 (2014).
55. Siddiqui S, Fang M, Ni B, Lu D, Martin B, Maudsley S. Central role of the EGF receptor in neurometabolic aging. Int. J. Endocrinol. 2012, 739428 (2012).
56. Ogino A, Kitao H, Hirano S et al. Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non-small cell lung cancer cell line. Cancer Res. 67(16), 7807-7814 (2007).
57. Lynch TJ, Kim ES, Eaby B, Garey J, West DP, Lacouture ME. Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist 12(5), 610-621 (2007).
58. Luo M, Kelley MR. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res. 24(4), 2127-2134 (2004).
59. Sun X, Liu Z, Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1(3), 203-212 (2008).
60. Wu AM, Senter PD. Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol. 23(9), 1137-1146 (2005).
61. Yang X, Zhang X, Ma Y, Huang Y, Wang Y, Chen Y. Superparamagnetic graphene oxide-Fe3O4 nanoparticles hybrid for controlled targeted drug carriers. J. Mater. Chem. 19(18), 2710-2714 (2009).
62. Yang X, Wang Y, Huang X et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dualtargeting function and pH-sensitivity. J. Mater. Chem. 21(10), 3448-3454 (2011).
63. Sun X, Liu Z, Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1(3), 203-212 (2008).
64. Felgner PL, Gadek TR, Holm M et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84(21), 7413-7417 (1987).
65. Notley SM, Crawford RJ, Ivanova EP.Bacterial interaction with graphene particles and surfaces. Nanotechnol. Nanomater. 5, 99-118 (2013).
66. Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114(1), 100-109 (2006).
67. Pérez-Martínez FC, Guerra J, Posadas I, Cenã V. Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharm. Res. 28(8), 1843-1858 (2011).
68. Li C, Zhong D, Zhang Y et al. The effect of the gene carrier material polyethyleneimine on the structure and function of human red blood cells in vitro. J. Mater. Chem. B, 1(14), 1885-1893 (2013).
69. Feng L, Zhang S, Liu Z. Graphene based gene transfection. Nanoscale 3(3), 1252-1257 (2011).
70. Chen B, Liu M, Zhang L, Huang J, Yao J, Zhang Z. Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector. J. Mater. Chem. 21(21), 7736-7741 (2011).
71. Kim H, Namgung R, Singha K, Oh I-K, Kim WJ. Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. Bioconjugate Chem. 22(12), 2558-2567 (2011).
72. Feng L, Yang X, Shi X et al. Polyethylene glycol and polyethylenimine dualfunctionalized nanographene oxide for photothermally enhanced gene delivery. Small 9(11), 1989-1997 (2013).
73. Ren T, Li L, Cai X, Dong H, Liu S, Li Y. Engineered polyethylenimine/graphene oxide nanocomposite for nuclear localized gene delivery. Polym. Chem. 3(9), 2561-2569 (2012).
74. Zhang L, Lu Z, Zhao Q, Huang J, Shen H, Zhang Z. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEIgrafted graphene oxide. Small 7(4), 460-464 (2011).
75. Zhi F, Dong H, Jia X et al. Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro. PLoS ONE 8(3), e60034 (2013).
76. Zhang J, Feng L, Tan X et al. Dualpolymerfunctionalized nanoscale graphene oxide as a highly effective gene transfection agent for insect cells with celltypedependent cellular uptake mechanisms. Part. Part. Syst. Char. 30(9), 794-803 (2013).
77. Zhou X, Laroche F, Lamers GE et al. Ultra-small graphene oxide functionalized with polyethylenimine (PEI) for very efficient gene delivery in cell and zebrafish embryos. Nano Res. 5(10), 703-709 (2012).
78. Yin D, Li Y, Lin H et al. Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo. Nanotechnologia 24(10), 105102 (2013).
79. Yang HW, Huang CY, Lin CW et al. Gadoliniumfunctionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging. Biomaterials 35(24), 6534-6542 (2014).
80. Lee ST, Chu K, Oh HJ et al. Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J. Neuro-Oncol. 102(1), 19-24 (2011).
81. Gollavelli G, Ling YC. Magnetic and fluorescent graphene for dual modal imaging and single light induced photothermal and photodynamic therapy of cancer cells. Biomaterials 35(15), 4499-4507 (2014).
82. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev. 24(1), 19-33 (1995).
83. Mensudar R. Photodynamic therapy-A review. World J. Med. Sci. 10(2), 139-142 (2014).
84. Zhou L, Wang W, Tang J, Zhou JH, Jiang HJ, Shen J. Graphene oxide noncovalent photosensitizer and its anticancer activity In vitro. Chem. Eur. J. 17(43), 12084-12091 (2011).
85. Wang S, Gao R, Zhou F, Selke M. Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. J. Mater. Chem. 14(4), 487-493 (2004).
86. Ravanat JL, Douki T, Cadet J. Direct and indirect effects of UV radiation on DNA and its components. Photochem. Photobiol. 63(1), 88-102 (2001).
87. Hu Z, Li J, Li C et al. Folic acid-conjugated graphene-ZnO nanohybrid for targeting photodynamic therapy under visible light irradiation. J. Mater. Chem. 1(38), 5003-5013 (2013).
88. Gilje S, Dubin S, Badakhshan A, Farrar J, Danczyk S, Kaner RB. Photothermal deoxygenation of graphene oxide for patterning and distributed ignition applications. Adv. Mater. 22(3), 419-423 (2010).
89. Abdelsayed V, Moussa S, Hassan HM, Aluri HS, Collinson MM, El-Shall MS. Photothermal deoxygenation of graphite oxide with laser excitation in solution and graphene-aided increase in water temperature. J. Phys. Chem. L.ett. 1(19), 2804-2809 (2010).
90. Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 32(4), 1121-1129 (2011).
91. Robinson JT, Tabakman SM, Liang Y et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J. Am. Chem. Soc. 133(17), 6825-6831 (2011).
92. Sasidharan A, Sivaram AJ, Retnakumari AP et al. Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene. Adv. Health Mater. 4(5), 679-684 (2015).
93. Sherlock SP, Tabakman SM, Xie L, Dai H. Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals. ACS Nano 5(2), 1505-1512 (2011).
94. Miao W, Shim G, Lee S, Lee S, Choe YS, Oh YK. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials 34(13), 3402-3410 (2013).
95. Tian B, Wang C, Zhang S, Feng L, Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 5(9), 7000-7009 (2011).
96. Sahu A, Choi WI, Lee JH, Tae G. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials 34(26), 6239-6248 (2013).
97. Park H, Yang J, Lee J, Haam S, Choi IH, Yoo KH. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano 3(10), 2919-2926 (2009).
98. Liu H, Chen D, Li L et al. Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew. Chem. Int. Ed. Engl. 123(4), 921-925 (2011).
99. Kim H, Lee D, Kim J, Kim TI, Kim WJ. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano 7(8), 6735-6746 (2013).
100. Zhang W, Guo Z, Huang D, Liu Z, Guo X, Zhong H. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 32(33), 8555-8561 (2011).
101. Ma X, Tao H, Yang K et al. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res 5(3), 199-212 (2012).
102. Feng L, Li K, Shi X, Gao M, Liu J, Liu Z. Smart pHresponsive nanocarriers based on nano-graphene oxide for combined chemo-and photothermal therapy overcoming drug resistance. Adv. Health Mater. 3(8), 1261-1271 (2014).
103. Bian X, Song ZL, Qian Y et al. Fabrication of grapheneisolated-Au-nanocrystal nanostructures for multimodal cell imaging and photothermal-enhanced chemotherapy. Sci. Rep. 4, 6093 (2014).
104. Qin XC, Guo ZY, Liu ZM, Zhang W, Wan MM, Yang BW. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. Photochem. Photobiol. 120(0), 156-162 (2013).
105. Bao H, Pan Y, Ping Y et al. Chitosanfunctionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 7(11), 1569-1578 (2011).
106. Sheng Z, Song L, Zheng J et al. Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy. Biomaterials 34(21), 5236-5243 (2013).
107. Bianco A. Graphene: safe or toxic The two faces of the medal. Angew. Chem. Int. Edit. 52(19), 4986-4997 (2013).
108. Seabra AB, Paula AJ, de Lima R, Alves OL, Duraán N. Nanotoxicity of graphene and graphene oxide. Chem. Res. Toxicol. 27(2), 159-168 (2014).
109. Jastrzbska AM, Kurtycz P, Olszyna AR. Recent advances in graphene family materials toxicity investigations. J. Nanopart. Res. 14(12), 1-21 (2012).
110. Ma Y, Shen H, Tu X, Zhang Z. Assessing in vivo toxicity of graphene materials: current methods and future outlook. Nanomedicine 9(10), 1565-1580 (2014).
111. Feng L, Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine 6(2), 317-324 (2011).
112. Zhou T, Zhang B, Wei P et al. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets. Biomaterials 35(37), 9833-9843 (2014).
113. Zhou H, Zhang B, Zheng J et al. The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration. Biomaterials 35(5), 1597-1607 (2014).
114. Jaworski S, Sawosz E, Grodzik M et al. In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells. Int. J. Nanomed. 8, 413 (2013).
115. Yuan X, Liu Z, Guo Z, Ji Y, Jin M, Wang X. Cellular distribution and cytotoxicity of graphene quantum dots with different functional groups. Nanoscale Res. Lett. 9(1), 1-9 (2014).
116. Chng ELK, Chua CK, Pumera M. Graphene oxide nanoribbons exhibit significantly greater toxicity than graphene oxide nanoplatelets. Nanoscale 6(18), 10792-10797 (2014).
117. Mbeh DA, Akhavan O, Javanbakht T, Mahmoudi M, Yahia LH. Cytotoxicity of protein corona-graphene oxide nanoribbons on human epithelial cells. Appl. Surf. Sci. 320, 596-601 (2014).
118. Mullick Chowdhury S, Dasgupta S, McElroy AE, Sitharaman B. Structural disruption increases toxicity of graphene nanoribbons. J. App. Toxicol. 34(11), 1235-1246 (2014).
119. Yang K, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 33(7), 2206-2214 (2012).
120. Nurunnabi M, Khatun Z, Huh KM et al. In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano 7(8), 6858-6867 (2013).
121. Meyer JC, Geim AK, Katsnelson MI, Novoselov KS, Booth TJ, Roth S. The structure of suspended graphene sheets. Nature 446(7131), 60-63 (2007).
122. Chen Y, Guo F, Jachak A et al. Aerosol synthesis of cargofilled graphene nanosacks. Nano Lett. 12(4), 1996-2002 (2012).
123. Park SH, Kim HK, Yoon SB et al. Spray-assisted deepfrying process for the In situ spherical assembly of graphene for energy-storage devices. Chem. Mater. 27(2), 457-465 (2015).
124. Moore TL, Pitzer JE, Podila R et al. Multifunctional polymer-coated carbon nanotubes for safe drug delivery. Part. Part. Sys. Char. 30(4), 365-373 (2013).
125. Paratala B, Hill L, Mujica-Parodi L, Caparelli E, Wadghiri Y, Sitharaman B. Graphene based MRI contrast agents: synthesis, characterization and in-vitro MRI. Proc. Int. Soc. Mag. Reson. Med. 19, 1678 (2011).
126. Lalwani G, Sundararaj JL, Schaefer K, Button T, Sitharaman B. Synthesis, characterization, in vitro phantom imaging, and cytotoxicity of a novel graphene-based multimodal magnetic resonance imaging-X-ray computed tomography contrast agent. J. Mater. Chem 2(22), 3519-3530 (2014).
127. Lalwani G, Cai X, Nie L, Wang LV, Sitharaman B. Graphene-based contrast agents for photoacoustic and thermoacoustic tomography. Photoacoustics 1(3-4), 62-67 (2013).
128. Huang J, Zong C, Shen H, Cao Y, Ren B, Zhang Z. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy. Nanoscale 5(21), 10591-10598 (2013).
129. Podila R, Brown JM. Toxicity of engineered nanomaterials: a physicochemical perspective. J. Biochem. Mol. Toxic 27(1), 50-55 (2013).
130. Wu C, Wang C, Han T, Zhou X, Guo S, Zhang J. Insight into the cellular internalization and cytotoxicity of graphene quantum dots. Adv. Health Mater. 2(12), 1613-1619 (2013).
131. Teo WZ, Chng EL, Sofer Z, Pumera M. Cytotoxicity of halogenated graphenes. Nanoscale 6(2), 1173-1180 (2014).
132. Akhavan O, Ghaderi E, Emamy H, Akhavan F. Genotoxicity of graphene nanoribbons in human mesenchymal stem cells. Carbon 54, 419-431 (2013).
133. Hashemi E, Akhavan O, Shamsara M, Rahighi R, Esfandiar A, Tayefeh AR. Cyto and genotoxicities of graphene oxide and reduced graphene oxide sheets on spermatozoa. RSC Adv. 4(52), 27213-27223 (2014).
134. Kanakia S, Toussaint JD, Mullick Chowdhury S et al. Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations. Biomaterials 35(25), 7022-7031 (2014).